Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pimecrolimus 0.3% ophthalmic ointment in blepharitis
NCT06400511Phase 3Terminated
- Sponsor
- Viatris
- Start
- Apr 2024
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Pimecrolimus vehicle + topical corticosteroid in blepharitis, sponsored by Viatris. Started Apr 2024; status: terminated.
02
Drugs
Pimecrolimus vehicle + topical corticosteroid
03
Conditions
blepharitis
Beyond the preview
Go deeper on NCT06400511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06400511.